Audioboom and Pharmaceutical Executive Podcast에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 Audioboom and Pharmaceutical Executive Podcast 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.
Player FM -팟 캐스트 앱
Player FM 앱으로 오프라인으로 전환하세요!
Player FM 앱으로 오프라인으로 전환하세요!
Tariffs and Drug Prices: Understanding the Impact on Pharmaceuticals
Manage episode 473037337 series 2084987
Audioboom and Pharmaceutical Executive Podcast에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 Audioboom and Pharmaceutical Executive Podcast 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.
In this Pharmaceutical Executive podcast epsiode, Peter Ax, Founder & CEO of UpScriptHealth, discusses:
- The impact of tariffs on the pharmaceutical industry, highlighting branded and generics medications
- How tariffs could lead to strategic supply chain changes, including potential US manufacturing shifts.
- How digital health platforms, like UpScriptHealth, can help reduce friction and costs in healthcare, potentially offsetting tariff impacts
- The importance of telehealth in ensuring medication availability
- Strategic partnerships between digital health platforms and pharma companies to improve patient care and access
- and more
178 에피소드
Manage episode 473037337 series 2084987
Audioboom and Pharmaceutical Executive Podcast에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 Audioboom and Pharmaceutical Executive Podcast 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.
In this Pharmaceutical Executive podcast epsiode, Peter Ax, Founder & CEO of UpScriptHealth, discusses:
- The impact of tariffs on the pharmaceutical industry, highlighting branded and generics medications
- How tariffs could lead to strategic supply chain changes, including potential US manufacturing shifts.
- How digital health platforms, like UpScriptHealth, can help reduce friction and costs in healthcare, potentially offsetting tariff impacts
- The importance of telehealth in ensuring medication availability
- Strategic partnerships between digital health platforms and pharma companies to improve patient care and access
- and more
178 에피소드
ทุกตอน
×P
Pharmaceutical Executive

1 Tariffs and Drug Prices: Understanding the Impact on Pharmaceuticals 17:36
17:36
나중에 재생
나중에 재생
리스트
좋아요
좋아요17:36
In this Pharmaceutical Executive podcast epsiode, Peter Ax, Founder & CEO of UpScriptHealth, discusses: The impact of tariffs on the pharmaceutical industry, highlighting branded and generics medications How tariffs could lead to strategic supply chain changes, including potential US manufacturing shifts. How digital health platforms, like UpScriptHealth, can help reduce friction and costs in healthcare, potentially offsetting tariff impacts The importance of telehealth in ensuring medication availability Strategic partnerships between digital health platforms and pharma companies to improve patient care and access and more…
P
Pharmaceutical Executive

1 The Misinformation Maze: Navigating Public Health in the Digital Age 24:22
24:22
나중에 재생
나중에 재생
리스트
좋아요
좋아요24:22
In this episode of the Pharmaceutical Executive podcast, Jennifer Butler, Chief Commercial Officer of Pleio, discusses: The threat of misinformation to public health and how emotional appeal plays a part Where patients are turning for trustworthy health information Strategies that can be used to verify information Pharma's role in helping to ensure patients have access to health insights they can trust Why the industry is turning to peer-to-patient platforms, trusted patient communities, and pharmacies to educate patients What kind of role regulatory agencies should play in the battle against misinformation and much more! Check out our new look and read our February issue here: https://www.pharmexec.com/journals/pharmaceutical-executive/pharmaceutical-executive-february-2025…
P
Pharmaceutical Executive

In this episode of the Pharmaceutical Executive Podcast, CEO and Founder of Sooth, Ian Baer, is back to discuss: The growing distrust in social media Why people trust friends and influencers over companies The EMA's departure from X Concerns about information accessibility The healthcare industry's trust gap "Dark Social" and SO MUCH MORE! Pharmaceutical Executive has a brand new look! Click through our February issue here: https://www.pharmexec.com/journals/pharmaceutical-executive/pharmaceutical-executive-february-2025…
P
Pharmaceutical Executive

1 Revolutionizing Patient Adherence: Leveraging AI for Personalized Engagement 19:23
19:23
나중에 재생
나중에 재생
리스트
좋아요
좋아요19:23
In this episode of the Pharmaceutical Executive podcast, Bill Grambley, CEO of AllazoHealth, delves into the potential of AI to revolutionize patient engagement and adherence. By utilizing patient-level data and predictive modeling, AI can identify individual needs and preferences, tailoring interventions to optimize treatment outcomes. This personalized approach addresses the common challenges of medication non-adherence and improves patient outcomes. The discussion highlights the importance of ethical considerations and data privacy when leveraging AI in healthcare. By focusing on patient well-being and using AI responsibly, healthcare providers can significantly enhance patient experiences and improve overall health outcomes.…
P
Pharmaceutical Executive

1 The Future of Fertility: AI, Personalized Medicine, and Ethical Considerations 30:12
30:12
나중에 재생
나중에 재생
리스트
좋아요
좋아요30:12
In this episode of the Pharmaceutical Executive podcast, Dr. Lawrence B. Werlin, MD, FACOG of HRC Fertility ( @md.lawrence.werlin on TikTok ), discusses the challenges of addressing fertility misinformation on social media. He emphasizes the importance of providing accurate and reliable information and encourages patients to consult with healthcare professionals. He also discusses the ethical considerations of using social media to share personal and professional experiences in the field of fertility and so much more!…
P
Pharmaceutical Executive

In this episode of the Pharmaceutical Executive podcast, Shubh Goel, Head of Immuno-Oncology and Gastrointestinal Tumors, US Oncology Business Unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer, and much more.…
P
Pharmaceutical Executive

1 Fake Weight Loss Drugs: Growing Threat to Consumer Health 21:15
21:15
나중에 재생
나중에 재생
리스트
좋아요
좋아요21:15
UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss: Counterfeit weight loss drugs (particularly fake Ozempic) and potential health risks What can be done to raise awareness among consumers about the dangers of counterfeit medications Ways increase access to legitimate weight loss medications, especially for those in underserved communities and much more!…
P
Pharmaceutical Executive

Brian Hillberdink, EVP, LEO Pharma and President of LEO Pharma's US affiliate, discusses how is they're positioning to capitalize on the unmet needs in other specific therapeutic areas, their approach to orphan drug development, challenges and opportunities adapting to the US market, and more.
P
Pharmaceutical Executive

1 Beyond the Birthrate: The Societal Costs of Maternal Morality 15:48
15:48
나중에 재생
나중에 재생
리스트
좋아요
좋아요15:48
In this episode of the Pharmaceutical Executive podcast, Charlotte Owens, MD, FACOG, Head of Medical Affairs and Outcomes Research at Organon discusses: The broader societal implications of these maternal health issues highlighted in The Commonwealth Fund study The most critical changes needed to close the gaps in R&D for maternal health solutions and how feasible they are to make Specific efforts Organon is undertaking to invest in research, education, and its pipeline to focus on critical areas of need in maternal health How her in-practice experience as an OB-GYN are informing Organon's strategic approach to addressing maternal health challenges and more!…
P
Pharmaceutical Executive

Michael Abrams, Managing Partner at Numerof & Associates discusses pharmacy deserts and the main factors that are contributing to the closures of both large and independent pharmacies, what alternative solutions can help ensure continued access to medications for all Americans (particularly those in underserved communities), some potential long term consequences if these pharmacy closures continue, and so much more…
P
Pharmaceutical Executive

1 The Weight-Loss Gold Rush: Legal and Regulatory Implications 17:10
17:10
나중에 재생
나중에 재생
리스트
좋아요
좋아요17:10
Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses: Top legal and regulatory concerns for investors considering when financing companies developing or marketing GLP-1 drugs How the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs What needs to be done for GLP-1s to be covered Steps companies developing weight-loss medications should take to ensure responsible and ethical practice Advice for investors and financiers who are considering entering the weight-loss medication market…
P
Pharmaceutical Executive

1 Healthcare Marketing Strategies for Reaching Diverse Audiences 13:10
13:10
나중에 재생
나중에 재생
리스트
좋아요
좋아요13:10
Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more. Link to Honeycomb Health video: https://www.pharmexec.com/view/going-beyond-visuals-to-connect-with-diverse-audiences…
P
Pharmaceutical Executive

Currax Pharmaceuticals CEO, George Hampton discusses what patient success has looked like for their oral anti-obesity medication, how expanded access can help with the world's obesity epidemic, when prices should come down, and much more.
P
Pharmaceutical Executive

In this week’s episode, in recognition of international women’s month, Editor Miranda Schmalfuhs has compiled audio clips from interviews with female KOLs that she's been fortunate enough to speak with over this past month for content across a few of our brands. Featured in this episode are: Emma Banks, CEO, ramarketing Jill Jaroch, Senior Director, Women’s Health & Urology Marketing, Astellas Marie Teil, Global Head, UCB’s Women of Childbearing Age Program Julia Lakeland, Chief Product Office, uMotif If you enjoyed this episode of our podcast, we encourage you to seek out the longer version of each of these videos—Linked on our website!…
Ian Baer, Founder and Chief Soothsayer, Sooth, discusses their recent data and research about some massive behavioral shifts occurring across Gen-Z, and how pharmaceutical companies and healthcare advertising agencies can adapt their strategies to attract the ever elusive generation.
플레이어 FM에 오신것을 환영합니다!
플레이어 FM은 웹에서 고품질 팟캐스트를 검색하여 지금 바로 즐길 수 있도록 합니다. 최고의 팟캐스트 앱이며 Android, iPhone 및 웹에서도 작동합니다. 장치 간 구독 동기화를 위해 가입하세요.